Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome.

Saved in:
Bibliographic Details
Title: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome.
Authors: Zhang H; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Dang Y; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Guo Y; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Fisher D; Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa., Hien NTT; Hai Phong University of Medicine and Pharmacy, Hai Phong, 04212, Viet Nam., Musabaev E; The Research Institute of Virology, Ministry of Health, Tashkent, 100122, Uzbekistan., Shmanai VV; Institute of Physical Organic Chemistry, National Academy of Sciences of Belarus, Surganova 13, Minsk, 220072, Belarus., Zhu Z; The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, 530023, China. Electronic address: 14650901@qq.com., Luo M; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. Electronic address: lm20200108@163.com., Ge C; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China. Electronic address: chunxia_ge@126.com., Zhao L; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: leizhao@hust.edu.cn.
Source: European journal of pharmacology [Eur J Pharmacol] 2026 May 28; Vol. 1025, pp. 178928. Date of Electronic Publication: 2026 May 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0712
DOI:10.1016/j.ejphar.2026.178928